Daily Almanac for
Dec 4, 2009
Search White Pages
Search: Infoplease Info search tips
Search: Biographies Bio search tips
Encyclopedia

infant respiratory distress syndrome

infant respiratory distress syndrome (IRDS) or hyaline membrane disease (hī'ulin, –līn") [key], respiratory distress syndrome of newborns, most common in infants born prematurely or by cesarean section or having a diabetic mother. The immature lungs of such infants cannot retain air; the air spaces empty completely and collapse after the first (and each succeeding) exhalation. Plasma leaks out of the lung tissue and coats the air spaces with a pink coating that is glassy, or hyaline, in appearance, hence the alternate name of the disease. Exhaustion, resulting from the extreme effort required to breathe, has been responsible for the death of many afflicted infants.

IRDS is caused by a lack, in the immature lung, of a surfactant agent; the substance, a mixture of lipids and proteins, contributes to the elasticity of lung tissue and stabilizes air passages so that the lung remains partly aerated after each exhalation. Intensive care, including supplemental oxygen and, in the case of severe symptoms, aid in breathing from a ventilator, can often bring infants through the first five or six days, after which most recover completely. An artificial surfactant may be introduced into the lungs if a newborn is at high risk for IRDS. If labor begins prematurely and cannot be halted and tests show that the fetus's lungs are immature, steroids administered to the mother a few days prior to labor may promote lung maturation.

The Columbia Electronic Encyclopedia, 6th ed. Copyright © 2007, Columbia University Press. All rights reserved.

    • Cite
    • Print
    • Bookmark

More on infant respiratory distress syndrome from Infoplease:

See more Encyclopedia articles on: Pathology


Premium Partner Content
HighBeam Research

Related content from HighBeam Research on: infant respiratory distress syndrome

Discovery Labs Files Surfaxin Application In RDS In Infants.(respiratory distress syndrome ) (BIOWORLD Today)

A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants. (Pediatrics)

THE INCREASING RACIAL DISPARITY IN INFANT MORTALITY: RESPIRATORY DISTRESS SYNDROME AND OTHER CAUSES* (Demography)

A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome. (Pediatrics)

First Intention High-Frequency Oscillation With Early Lung Volume Optimization Improves Pulmonary Outcome in Very Low Birth Weight Infants With Respiratory Distress Syndrome. (Pediatrics)

Neutrophil activation in preterm infants who have respiratory distress syndrome. (Pediatrics)

Multicenter controlled clinical trial of high-frequency jet ventilation in preterm infants with uncomplicated respiratory distress syndrome. (Pediatrics)

All's quiet in the NICU: infant RDS: there are challenges 24/7 in NICUs that treat premature infants with RDS. A team approach helps both patients and parents through the days and weeks, and sometimes months, ahead.(neonatal intensive care unit, respiratory distress syndrome) (RT)

ONTOGENY OF PRO- AND ANTI-INFLAMMATORY CYTOKINES IN BRONCHOALVEOLAR LAVAGE (BAL) IN PRETERM INFANTS WITH RESPIRATORY DISTRESS SYNDROME.(Abstract) (Pediatrics)

RANDOMIZED DOUBLE-BLIND TRIAL OF DOPAMINE VERSUS EPINEPHRINE FOR TREATMENT OF HYPOTENSION IN PREMATURE INFANTS WITH RESPIRATORY DISTRESS SYNDROME.(Abstract) (Pediatrics)

Additional search results provided by HighBeam Research, LLC. © Copyright 2005. All rights reserved.